IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

RAZINI, PAOLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 3.293
AS - Asia 2.809
NA - Nord America 2.759
SA - Sud America 300
AF - Africa 52
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 3
Totale 9.225
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.651
CN - Cina 925
SG - Singapore 891
GB - Regno Unito 887
DE - Germania 529
IT - Italia 405
SE - Svezia 385
HK - Hong Kong 292
RU - Federazione Russa 291
BR - Brasile 217
NL - Olanda 210
IN - India 154
UA - Ucraina 131
FR - Francia 130
TR - Turchia 124
VN - Vietnam 112
KR - Corea 94
BD - Bangladesh 85
FI - Finlandia 81
CA - Canada 78
IE - Irlanda 77
EU - Europa 75
PL - Polonia 54
CO - Colombia 37
JP - Giappone 28
GR - Grecia 24
CI - Costa d'Avorio 21
DK - Danimarca 18
ID - Indonesia 18
BE - Belgio 17
AR - Argentina 16
IQ - Iraq 15
MX - Messico 15
PH - Filippine 13
ES - Italia 12
RO - Romania 11
ZA - Sudafrica 10
VE - Venezuela 8
AU - Australia 7
UZ - Uzbekistan 7
CL - Cile 6
MA - Marocco 6
SA - Arabia Saudita 6
AT - Austria 5
CH - Svizzera 5
EC - Ecuador 5
IL - Israele 5
AZ - Azerbaigian 4
IR - Iran 4
JM - Giamaica 4
PK - Pakistan 4
PY - Paraguay 4
TW - Taiwan 4
AE - Emirati Arabi Uniti 3
CR - Costa Rica 3
EG - Egitto 3
KE - Kenya 3
LB - Libano 3
LT - Lituania 3
NP - Nepal 3
PE - Perù 3
TH - Thailandia 3
TT - Trinidad e Tobago 3
UY - Uruguay 3
BG - Bulgaria 2
BY - Bielorussia 2
DZ - Algeria 2
ET - Etiopia 2
HR - Croazia 2
JO - Giordania 2
KG - Kirghizistan 2
KZ - Kazakistan 2
LU - Lussemburgo 2
MY - Malesia 2
NZ - Nuova Zelanda 2
PA - Panama 2
PS - Palestinian Territory 2
AO - Angola 1
BA - Bosnia-Erzegovina 1
BO - Bolivia 1
CZ - Repubblica Ceca 1
GT - Guatemala 1
LV - Lettonia 1
MD - Moldavia 1
MK - Macedonia 1
MT - Malta 1
MU - Mauritius 1
NI - Nicaragua 1
NO - Norvegia 1
PT - Portogallo 1
QA - Qatar 1
RS - Serbia 1
SI - Slovenia 1
SN - Senegal 1
SO - Somalia 1
TL - Timor Orientale 1
UG - Uganda 1
VG - Isole Vergini Britanniche 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 9.298
Salva come PNG Salva come JPEG
Città #
Southend 802
Singapore 537
Hong Kong 278
Chandler 247
Ashburn 241
Beijing 238
Frankfurt am Main 205
San Jose 161
Princeton 119
Seattle 118
Milan 109
Santa Clara 104
Wilmington 103
Jacksonville 96
Mountain View 88
Dublin 76
Los Angeles 75
Council Bluffs 74
Redmond 70
Dallas 69
Ann Arbor 66
Nanjing 66
Boardman 65
Bengaluru 60
Phoenix 58
Moscow 56
Toronto 52
Warsaw 52
Lauterbourg 49
Munich 48
Dearborn 44
Sakarya 44
Buffalo 38
Medford 37
New York 37
Des Moines 36
Guangzhou 35
Andover 34
Shanghai 34
Bogotá 31
Fairfield 30
Serra 30
Ho Chi Minh City 29
Somerville 29
Helsinki 28
Tianjin 26
Woodbridge 25
Athens 23
Hanoi 23
Abidjan 21
Eitensheim 21
Jinan 21
Mumbai 20
Changsha 19
Fuzhou 19
Tokyo 19
Hamburg 18
Houston 17
Nanchang 17
Rome 17
Shenyang 17
Sunnyvale 17
São Paulo 17
Brussels 15
Hangzhou 15
Odernheim 15
Chicago 13
Hebei 13
Roxbury 12
Columbus 11
Falkenstein 11
Falls Church 11
The Dalles 11
Zhengzhou 11
Haikou 10
London 10
Bitonto 9
Cangzhou 9
Jiaxing 9
Orem 9
Quanzhou 9
San Diego 9
Nürnberg 8
Ottawa 8
Portici 8
Redwood City 8
Seoul 8
Hefei 7
Istanbul 7
Kunming 7
Lanzhou 7
Norwalk 7
Porto Alegre 7
Portsmouth 7
Brooklyn 6
Cambridge 6
Jakarta 6
Mainz 6
Ningbo 6
Noginsk 6
Totale 5.592
Salva come PNG Salva come JPEG
Nome #
Modificazione genica di cellule staminali distrofiche allo scopo di trapianto autologo nella distrofia muscolare di Duchenne 337
Impaired Angiogenic Potential of Human Placental Mesenchymal Stromal Cells in Intrauterine Growth Restriction 314
Expression of CD20 reveals a new store-operated calcium entry modulator in skeletal muscle 284
Stem cells and muscular dystrophies 246
Combining Stem Cell and Exon Skipping Approach to Treat Muscular Dystrophies 235
CD20-related signaling pathway is differently activated in normal and dystrophic circulating CD133+ stem cells 224
Heterogeneous tumorigenic capacity of human brain tumor derived neurospheres 224
Stem cell-mediated exon skipping of the dystrophin gene by the bystander effect 223
Absence of T and B lymphocytes modulates dystrophic features in dysferlin deficient animal model 220
Role of mesenchymal stem cells in human IUGR placentas 209
Heterogeneous tumourogenic ability of human brain tumour derived neurospheres 208
Autologous transplantation of bone marrow-derived CD133+ stem cells in facioscapulohumeral dystrophy 208
Stem Cell Salvage of injured peripheral nerve 208
Development of a new technique for muscle tissues-stem cells co-colture 207
Heterogeneous tumorigenic capacity of human brain tumor derived neurospheres 205
Combining gene and stem cell therapy in the treatment of disferlinopaties 201
Perspectives of Stem Cell Therapy in Duchenne Muscular Dystrophy 198
MicroRNA-206 is upregulated in an animal model of Duchenne Muscular Distrophy 196
In Vivo Tracking of Stem cell by Nanotechnologies : Future Prospect for Mouse to Human Translation 194
Cell Therapy of Muscular Dystrophy with Engineered CD133+ Cells 192
Cell Theraphy of Muscolar Dystrophy with Engineered CD133+Cell 191
Absence of T and B lymphocytes modulates dystrophic features in dysferlin deficient animal model 190
Full-length dysferlin expression driven by engineered human dystrophic blood-derived CD133+ stem cells 189
MicroRNA-206 is upregulated in an animal model of Duchenne Muscular Distrophy. 188
Development of new technologies Including myogenic differentiation of human circulating CD133+cells 187
Ex vivo expansion of human circulating CD133+ progenitors cells: promising tool for cell-based therapeutic approaches in muscular dystrophy. 184
Combining Gene and Stem Cell therapy in the Treatment of Dysferlinophaties 183
Preclinical experience and perspectives of a clinical trial using cD133 stem cells 179
Cell Based Therapy for Duchenne Muscular Dystrophy 175
Ex vivo expansion of peripheral blood CD133+ progenitors cells: promising tool for cell-based therapeutic approaches in muscular dystrophy. 172
Exon-skipping of dysferlin in CD133+ stem cells isolated from normal and patient affected with dysferlinopathies. 172
Development of New technologies Inducing Myogenic Differentiation of Human Circulating CD133+ Cells 169
Proliferation and clonal characterization of human muscle derived CD133+ positive stem cells define an intrinsic heterogeneity 169
Proliferation and Clonal Analysis of Muscle Derived CD133+ Stem Cell Subpopulations Define a Depletion of Mesenchymal Population in DMD Patients 169
Myogenic differentiation potential of CD133+ stem cells isolated from various sources 166
Muscle Cell Sheet-polymer Film generation and Transplantation for the Treatment of Muscular Dystrophy 164
Combining Stem Cells and Exon-Skipping and Approch to Treat Muscular Dystrophies 164
Differential Activation of CD20-related Signaling Pathways Results in distinct differentiation behaviour of normal and DMD circulating CD133+ Stem Cells 162
Human Fetal CD133+ Muscle Cells Expressing Perycite Markers Repair Dystrophic Muscle Tissue. 156
Perturbation of calcium handling in CD133+ stem cells isolated from DMD blood 152
X-Ray Synchrotron-Radiation Phase-Contras Analysis of Human and Mouse Progenitors in Culture on Engineering Scaffolds 148
Stem Cell Tracking by Nanotechnologies 147
In vivo Myogenic Potential of Human CD133+ Muscle-derived Stem Cells: A quantitative Study 141
Proliferation and clonal Characterization of Human Muscle Derived CD133+ Stem Cell Define an Intrinsic Heterogeneity 138
Perturbation of calcium handling in CD133+ stem cells isolated from DMD blood 136
Exon-Skipping of Dysferlin in CD133+ Stem Cells Isolated from normal and patient affected with Dysferlinopathies 134
Proliferation and Clonal Characterization of Human muscle Derived CD 133+ stem cell Define an Heterogeneity 133
Stem Cell Salvage of injured peripheral nerve 133
Difference in Myogenic properties of the human blood-derived stem cells subpopulation isolated from normal and dystrophic tissues 121
Exon-skipping of dysferlin in CD133+ stem cells isolated from normal and patient affected with dysferlinopathies 115
Combining stem cells and exon skipping strategy to treat dystrophic GRMD dogs 115
Novel insight into stem cell trafficking in dystrophic muscles 113
Full-Length Dysferlin Expression Driven by Engineered Human Dystrophic Blood-Derived CD133+ Stem Cells 76
null 47
Combining gene and stem cell therapy in the treatment of dysferlinophaties 1
Stem cell salvage of injured peripheral nerve 1
Autologous transplantation of bone marrow-derived CD133+stem cells in facioscapulohumeral dystrophy 1
Stem cell therapy of muscular dystrophies using exon skipping approach in GRMD dogs 1
Totale 9.715
Salva come PNG Salva come JPEG
Categoria #
all - tutte 25.019
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 25.019
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202110 0 0 0 0 0 0 0 0 0 0 0 10
2021/2022582 64 21 4 31 28 36 57 15 71 36 69 150
2022/2023963 142 105 86 87 113 167 9 74 138 6 22 14
2023/2024542 18 34 15 40 153 24 33 33 11 47 55 79
2024/20251.408 54 120 34 204 105 21 83 127 55 189 81 335
2025/20262.469 290 137 186 183 261 181 402 135 244 202 182 66
Totale 9.715